A Multiinstitutional Phase 2 Trial of Pazopanib Monotherapy in Advanced Anaplastic Thyroid Cancer

CONTEXT/OBJECTIVES: Pazopanib, an inhibitor of kinases including vascular endothelial growth factor receptor, demonstrated impressive activity in progressive metastatic differentiated thyroid cancer, prompting its evaluation in anaplastic thyroid cancer (ATC). DESIGN/SETTING/PATIENTS/INTERVENTIONS/O...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bible, Keith C., Suman, Vera J., Menefee, Michael E., Smallridge, Robert C., Molina, Julian R., Maples, William J., Karlin, Nina J., Traynor, Anne M., Kumar, Priya, Goh, Boon Cher, Lim, Wan-Teck, Bossou, Ayoko R., Isham, Crescent R., Webster, Kevin P., Kukla, Andrea K., Bieber, Carolyn, Burton, Jill K., Harris, Pamela, Erlichman, Charles
Formato: Artigo
Idioma:Inglês
Publicado em: Endocrine Society 2012
Assuntos:
Endocrine Care
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3431569/
https://ncbi.nlm.nih.gov/pubmed/22774206
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2012-1520
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados